Your browser doesn't support javascript.
loading
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease.
Yoo, Taekyeong; Joo, Sae Kyung; Kim, Hyo Jung; Kim, Hyun Young; Sim, Hyungtai; Lee, Jieun; Kim, Hee-Hoon; Jung, Sunhee; Lee, Youngha; Jamialahmadi, Oveis; Romeo, Stefano; Jeong, Won-Il; Hwang, Geum-Sook; Kang, Keon Wook; Kim, Jae Woo; Kim, Won; Choi, Murim.
Affiliation
  • Yoo T; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Joo SK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea.
  • Kim HJ; Department of Biochemistry and Molecular Biology, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Sim H; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea.
  • Kim HH; Laboratory of Liver Research, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Republic of Korea.
  • Jung S; Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul, Republic of Korea.
  • Lee Y; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Jamialahmadi O; Salhgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden.
  • Romeo S; Salhgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden; Sahlgrenska University Hospital, Cardiology Department, Sweden; Department of Medical and Clinical Science, Clinical Nutrition Unit, University Magna Graecia, Catanzaro, Italy
  • Jeong WI; Laboratory of Liver Research, Graduate School of Medical Science and Engineering, KAIST, Daejeon, Republic of Korea.
  • Hwang GS; Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul, Republic of Korea; Department of Chemistry & Nanoscience, Ewha Womans University, Seoul, Republic of Korea.
  • Kang KW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Kim JW; Department of Biochemistry and Molecular Biology, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim W; Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea. Electronic address: drwon1@snu.ac.kr.
  • Choi M; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: murimchoi@snu.ac.kr.
J Hepatol ; 75(3): 514-523, 2021 09.
Article in En | MEDLINE | ID: mdl-33892010

Full text: 1 Database: MEDLINE Main subject: Mass Screening / Non-alcoholic Fatty Liver Disease / Transaminases Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Mass Screening / Non-alcoholic Fatty Liver Disease / Transaminases Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article